rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2006-12-5
|
pubmed:databankReference |
|
pubmed:abstractText |
Smoking cessation after myocardial infarction reduces cardiovascular mortality, but many smokers cannot quit despite state-of-the-art counseling intervention. Bupropion is effective for smoking cessation, but its safety and efficacy in hospitalized smokers with acute cardiovascular disease is unknown.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1555-7162
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
119
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1080-7
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:17145253-Acute Disease,
pubmed-meshheading:17145253-Angina, Unstable,
pubmed-meshheading:17145253-Antidepressive Agents, Second-Generation,
pubmed-meshheading:17145253-Bupropion,
pubmed-meshheading:17145253-Double-Blind Method,
pubmed-meshheading:17145253-Female,
pubmed-meshheading:17145253-Hospitalization,
pubmed-meshheading:17145253-Humans,
pubmed-meshheading:17145253-Male,
pubmed-meshheading:17145253-Middle Aged,
pubmed-meshheading:17145253-Myocardial Infarction,
pubmed-meshheading:17145253-Smoking
|
pubmed:year |
2006
|
pubmed:articleTitle |
Bupropion for smokers hospitalized with acute cardiovascular disease.
|
pubmed:affiliation |
Tobacco Research and Treatment Center, General Medicine Division, and Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Mass 02114, USA. nrigotti@partners.org
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Research Support, N.I.H., Extramural
|